The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Healthcare Nanomedicine Market Research Report 2024
Synopsis
Healthcare nanomedicine refers to the application of nanotechnology in the field of medicine and healthcare. Nanotechnology involves manipulating materials at the nanoscale, typically at the level of atoms and molecules, to create structures and devices with unique properties and capabilities. When applied to healthcare, nanomedicine offers promising solutions for disease diagnosis, treatment, and prevention.
Global Healthcare Nanomedicine market is projected to reach US$ 392310 million in 2029, increasing from US$ 201240 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare Nanomedicine market research.
Key companies engaged in the Healthcare Nanomedicine industry include Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen and Gilead Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Healthcare Nanomedicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Healthcare Nanomedicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Healthcare Nanomedicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amgen
Teva Pharmaceuticals
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Gilead Sciences
Pfizer
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Segment by Type
Nanoparticle Drug
Nanocarrier Drug
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare Nanomedicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Healthcare nanomedicine refers to the application of nanotechnology in the field of medicine and healthcare. Nanotechnology involves manipulating materials at the nanoscale, typically at the level of atoms and molecules, to create structures and devices with unique properties and capabilities. When applied to healthcare, nanomedicine offers promising solutions for disease diagnosis, treatment, and prevention.
Global Healthcare Nanomedicine market is projected to reach US$ 392310 million in 2029, increasing from US$ 201240 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare Nanomedicine market research.
Key companies engaged in the Healthcare Nanomedicine industry include Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen and Gilead Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Healthcare Nanomedicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Healthcare Nanomedicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Healthcare Nanomedicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amgen
Teva Pharmaceuticals
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Gilead Sciences
Pfizer
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Segment by Type
Nanoparticle Drug
Nanocarrier Drug
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare Nanomedicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare Nanomedicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nanoparticle Drug
1.2.3 Nanocarrier Drug
1.3 Market by Application
1.3.1 Global Healthcare Nanomedicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare Nanomedicine Market Perspective (2018-2029)
2.2 Healthcare Nanomedicine Growth Trends by Region
2.2.1 Global Healthcare Nanomedicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Healthcare Nanomedicine Historic Market Size by Region (2018-2023)
2.2.3 Healthcare Nanomedicine Forecasted Market Size by Region (2024-2029)
2.3 Healthcare Nanomedicine Market Dynamics
2.3.1 Healthcare Nanomedicine Industry Trends
2.3.2 Healthcare Nanomedicine Market Drivers
2.3.3 Healthcare Nanomedicine Market Challenges
2.3.4 Healthcare Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanomedicine Players by Revenue
3.1.1 Global Top Healthcare Nanomedicine Players by Revenue (2018-2023)
3.1.2 Global Healthcare Nanomedicine Revenue Market Share by Players (2018-2023)
3.2 Global Healthcare Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare Nanomedicine Revenue
3.4 Global Healthcare Nanomedicine Market Concentration Ratio
3.4.1 Global Healthcare Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanomedicine Revenue in 2022
3.5 Healthcare Nanomedicine Key Players Head office and Area Served
3.6 Key Players Healthcare Nanomedicine Product Solution and Service
3.7 Date of Enter into Healthcare Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare Nanomedicine Breakdown Data by Type
4.1 Global Healthcare Nanomedicine Historic Market Size by Type (2018-2023)
4.2 Global Healthcare Nanomedicine Forecasted Market Size by Type (2024-2029)
5 Healthcare Nanomedicine Breakdown Data by Application
5.1 Global Healthcare Nanomedicine Historic Market Size by Application (2018-2023)
5.2 Global Healthcare Nanomedicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Healthcare Nanomedicine Market Size (2018-2029)
6.2 North America Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Healthcare Nanomedicine Market Size by Country (2018-2023)
6.4 North America Healthcare Nanomedicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare Nanomedicine Market Size (2018-2029)
7.2 Europe Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Healthcare Nanomedicine Market Size by Country (2018-2023)
7.4 Europe Healthcare Nanomedicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanomedicine Market Size (2018-2029)
8.2 Asia-Pacific Healthcare Nanomedicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare Nanomedicine Market Size (2018-2029)
9.2 Latin America Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Healthcare Nanomedicine Market Size by Country (2018-2023)
9.4 Latin America Healthcare Nanomedicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanomedicine Market Size (2018-2029)
10.2 Middle East & Africa Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Healthcare Nanomedicine Introduction
11.1.4 Amgen Revenue in Healthcare Nanomedicine Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Healthcare Nanomedicine Introduction
11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanomedicine Business (2018-2023)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 UCB
11.3.1 UCB Company Detail
11.3.2 UCB Business Overview
11.3.3 UCB Healthcare Nanomedicine Introduction
11.3.4 UCB Revenue in Healthcare Nanomedicine Business (2018-2023)
11.3.5 UCB Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Healthcare Nanomedicine Introduction
11.4.4 Roche Revenue in Healthcare Nanomedicine Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Healthcare Nanomedicine Introduction
11.5.4 Celgene Revenue in Healthcare Nanomedicine Business (2018-2023)
11.5.5 Celgene Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Healthcare Nanomedicine Introduction
11.6.4 Sanofi Revenue in Healthcare Nanomedicine Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Detail
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Healthcare Nanomedicine Introduction
11.7.4 Merck & Co Revenue in Healthcare Nanomedicine Business (2018-2023)
11.7.5 Merck & Co Recent Development
11.8 Biogen
11.8.1 Biogen Company Detail
11.8.2 Biogen Business Overview
11.8.3 Biogen Healthcare Nanomedicine Introduction
11.8.4 Biogen Revenue in Healthcare Nanomedicine Business (2018-2023)
11.8.5 Biogen Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Healthcare Nanomedicine Introduction
11.9.4 Gilead Sciences Revenue in Healthcare Nanomedicine Business (2018-2023)
11.9.5 Gilead Sciences Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Healthcare Nanomedicine Introduction
11.10.4 Pfizer Revenue in Healthcare Nanomedicine Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Detail
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Healthcare Nanomedicine Introduction
11.11.4 Leadiant Biosciences Revenue in Healthcare Nanomedicine Business (2018-2023)
11.11.5 Leadiant Biosciences Recent Development
11.12 Kyowa Hakko Kirin
11.12.1 Kyowa Hakko Kirin Company Detail
11.12.2 Kyowa Hakko Kirin Business Overview
11.12.3 Kyowa Hakko Kirin Healthcare Nanomedicine Introduction
11.12.4 Kyowa Hakko Kirin Revenue in Healthcare Nanomedicine Business (2018-2023)
11.12.5 Kyowa Hakko Kirin Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Healthcare Nanomedicine Introduction
11.13.4 Takeda Revenue in Healthcare Nanomedicine Business (2018-2023)
11.13.5 Takeda Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Detail
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Healthcare Nanomedicine Introduction
11.14.4 Ipsen Revenue in Healthcare Nanomedicine Business (2018-2023)
11.14.5 Ipsen Recent Development
11.15 Endo International
11.15.1 Endo International Company Detail
11.15.2 Endo International Business Overview
11.15.3 Endo International Healthcare Nanomedicine Introduction
11.15.4 Endo International Revenue in Healthcare Nanomedicine Business (2018-2023)
11.15.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
